Gene · 5396
Papers1,667
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,667
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development and Validation of a Functional Antibody Assay for Evaluating Protein-Based Pneumococcal Vaccines. | Vaccines (Basel) | 2026 | 41746050 | PubTator, text mining | PubMed |
Rapid Drug Sensitivity Profiling via a Novel High-Success-Rate Culture Method for Patient-Derived Pancreatic Cancer: An Exploratory Preclinical Platform for Advancing Clinical Applications and Drug Development. | Cells | 2026 | 41744756 | PubTator, text mining | PubMed |
| Temporal dynamics in cancer immunotherapy: the interplay between circadian rhythms, tumor microenvironment, and immune checkpoint blockade. | J Natl Cancer Cent | 2026 | 41738042 | PubTator, text mining | PubMed |
| SQSTM1/p62-mediated PD-L1 biomolecular condensate formation promotes lung tumorigenesis. | J Adv Res | 2026 | 41730411 | PubTator, text mining | PubMed |
| Analysis of the Matrix Metalloproteinases Family Profile in Gastric Cancer Suggests Key Matrix Metalloproteinases for Tumor Development and Their Clinical Impact. | Mol Carcinog | 2026 | 41728806 | PubTator, text mining | PubMed |
| Evolution of Cancer Metastases via Lineage Trans-Differentiation. | Research (Wash D C) | 2026 | 41726769 | PubTator, text mining | PubMed |
| RNA-binding protein BICC1 promotes gastric cancer progression via the PRRX1-MAPK signaling axis. | Funct Integr Genomics | 2026 | 41714520 | PubTator, text mining | PubMed |
| Clinicopathological Characteristics of PRRX1 and PRRX2 Genes Expressions in Colorectal Cancer Patients. | Cell Mol Biol (Noisy-le-grand) | 2026 | 41684173 | PubTator, text mining | PubMed |
| CRISPR-mediated conditional mutagenesis of Smad1/5/8 reveals BMP/GDF signaling restricts postnatal bone overgrowth. | bioRxiv | 2026 | 41648317 | PubTator, text mining | PubMed |
| FOXI3 establishes the ectodermal niche in pharyngeal arches for cranial neural crest cells and their lineages. | Bone Res | 2026 | 41639043 | PubTator, text mining | PubMed |
| RETRACTION: Fatty Acid Synthase Contributes to Epithelial-Mesenchymal Transition and Invasion of Salivary Adenoid Cystic Carcinoma Through PRRX1/Wnt/β-Catenin Pathway. | J Cell Mol Med | 2026 | 41631388 | PubTator, text mining | PubMed |
| A protein-based pneumococcal vaccine elicits broad immunity associated with multifunctional antibody responses in humans. | J Clin Invest | 2026 | 41623167 | PubTator, text mining | PubMed |
| Partial-EMT in oral squamous cell carcinoma: molecular circuitry and clinical translation. | Int J Oral Sci | 2026 | 41611665 | PubTator, text mining | PubMed |
| Association of Gene Polymorphism at Atrial Fibrillation in the Kazakh Population: Case-Control Study. | Genes (Basel) | 2026 | 41595504 | PubTator, text mining | PubMed |
| A novel molecular classifier enabling identification and prediction on immunotherapeutic response for MYCN-low pediatric neuroblastoma. | Cell Oncol (Dordr) | 2026 | 41553393 | PubTator, text mining | PubMed |
| NNMT Orchestrates Metabolic-Epigenetic Reprogramming to Drive Macrophage-Myofibroblast Transition in Hypertrophic Scarring. | Adv Sci (Weinh) | 2026 | 41211625 | PubTator, text mining | PubMed |
| PRRX1 -rearranged Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 18 Cases Including a Novel PRRX1::EP300 Fusion. | Am J Surg Pathol | 2026 | 41036703 | PubTator, text mining | PubMed |
| Neuronal injury and hepatotoxicity: astrocytes and stellate cells convergence and their role in tissue repair. | Front Neurosci | 2025 | 41710466 | PubTator, text mining | PubMed |
| Linoleic Hydroperoxides Are Potent Hyperoxidative Agents of Sensitive and Robust Typical 2-Cys Peroxiredoxins. | Antioxidants (Basel) | 2025 | 41462622 | PubTator, text mining | PubMed |
| PEGylated black-phosphorus nanosheet-alginate hydrogels enable local PRRX1 delivery to drive fibroblast reprogramming in intestinal fibrosis. | J Nanobiotechnology | 2025 | 41350883 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5396/papers?page=2